Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine.

Abstract

Although carcinosarcoma occurs in various locations throughout the body, it rarely originates in the ovary. Chemotherapy has been minimally beneficial. This case describes a patient with carcinosarcoma of the ovary who responded minimally to chemotherapy used for epithelial carcinomas but had a complete response after receiving chemotherapy used for sarcomas. The patient relapsed within 1 year after receiving cisplatin therapy. She was treated with mesna, ifosfamide, Adriamycin, and dacarbazine (MAID) chemotherapy and after one cycle of chemotherapy she had no evidence of tumor. She has received six cycles of chemotherapy without evidence of progression 13+ months since beginning MAID therapy. MAID chemotherapy may be useful in the treatment of carcinosarcoma of the ovary.

• Authors: S R Simon, S E Wang, M Uhl, S Shackney
• Journal: Gynecologic oncology (Gynecol Oncol) Vol. 41 Issue 2 Pg. 161-6 (May 1991) ISSN: 0090-8258 [Print] United States
• PMID: 2050307 (Publication Type: Case Reports, Journal Article)

Chemical References

• Dacarbazine
• Doxorubicin
• Ifosfamide

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carcinosarcoma (diagnostic imaging, drug therapy, pathology)
• Combined Modality Therapy
• Dacarbazine (administration & dosage)
• Doxorubicin (administration & dosage)
• Female
• Humans
• Ifosfamide (administration & dosage)
• Middle Aged
• Ovarian Neoplasms (diagnostic imaging, drug therapy, pathology)
• Pelvis (diagnostic imaging)
• Tomography, X-Ray Computed